These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7812482)

  • 1. Corticosteroids and peptic ulceration.
    Ellershaw JE; Kelly MJ
    Palliat Med; 1994 Oct; 8(4):313-9. PubMed ID: 7812482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of NSAID associated gastrointestinal disease.
    Wolfe F
    Eur J Rheumatol Inflamm; 1991; 11(3):12-28. PubMed ID: 1365476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P; McCauley DL
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 10. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects].
    Hiraishi H; Akima T; Sugaya T; Nakano M; Nomura M
    Nihon Rinsho; 2011 Jun; 69(6):988-94. PubMed ID: 21688617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids and ulcers: is there an association?
    Pecora PG; Kaplan B
    Ann Pharmacother; 1996; 30(7-8):870-2. PubMed ID: 8826575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery in the management of the gastric side-effects of NSAIDs.
    Venables CW
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():97-111. PubMed ID: 2979288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity.
    Griffin MR; Scheiman JM
    Am J Med; 2001 Jan; 110(1A):33S-37S. PubMed ID: 11165994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids.
    Henry DA; Johnston A; Dobson A; Duggan J
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1227-9. PubMed ID: 3120956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].
    Florent C; Desaint B
    Gastroenterol Clin Biol; 1989 Mar; 13(3):235-8. PubMed ID: 2731675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
    Koelz HR
    Schweiz Rundsch Med Prax; 1994 Jun; 83(25-26):768-71. PubMed ID: 8029591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D; McGettigan P
    Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M; Bertschinger P
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.